Sartorius Stedim Biotech Future Growth
Future criteria checks 4/6
Sartorius Stedim Biotech is forecast to grow earnings and revenue by 31.9% and 10.5% per annum respectively. EPS is expected to grow by 31.6% per annum. Return on equity is forecast to be 13.7% in 3 years.
Key information
31.9%
Earnings growth rate
31.6%
EPS growth rate
Life Sciences earnings growth | 18.5% |
Revenue growth rate | 10.5% |
Future return on equity | 13.7% |
Analyst coverage | Good |
Last updated | 23 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,357 | 447 | 410 | 840 | 12 |
12/31/2025 | 3,003 | 340 | 333 | 748 | 12 |
12/31/2024 | 2,772 | 212 | 303 | 672 | 12 |
9/30/2024 | 2,736 | 161 | 504 | 866 | N/A |
6/30/2024 | 2,747 | 170 | 305 | 706 | N/A |
3/31/2024 | 2,716 | 255 | 169 | 636 | N/A |
12/31/2023 | 2,776 | 310 | 273 | 746 | N/A |
9/30/2023 | 2,959 | 460 | 113 | 625 | N/A |
6/30/2023 | 3,170 | 635 | 162 | 675 | N/A |
3/31/2023 | 3,356 | 717 | 137 | 606 | N/A |
12/31/2022 | 3,493 | 876 | 182 | 612 | N/A |
9/30/2022 | 3,381 | 681 | 125 | 552 | N/A |
6/30/2022 | 3,259 | 625 | 193 | 584 | N/A |
3/31/2022 | 3,094 | 559 | 322 | 661 | N/A |
12/31/2021 | 2,887 | 414 | 378 | 702 | N/A |
9/30/2021 | 2,639 | 523 | 355 | 623 | N/A |
6/30/2021 | 2,393 | 469 | 367 | 590 | N/A |
3/31/2021 | 2,143 | 398 | 310 | 506 | N/A |
12/31/2020 | 1,910 | 336 | 258 | 417 | N/A |
9/30/2020 | 1,743 | 299 | 299 | 414 | N/A |
6/30/2020 | 1,600 | 255 | 243 | 365 | N/A |
3/31/2020 | 1,520 | 254 | 216 | 345 | N/A |
12/31/2019 | 1,441 | 235 | 174 | 310 | N/A |
9/30/2019 | 1,393 | 247 | 142 | 291 | N/A |
6/30/2019 | 1,336 | 238 | 21 | 261 | N/A |
3/31/2019 | 1,274 | 223 | 88 | 270 | N/A |
12/31/2018 | 1,212 | 208 | 51 | 227 | N/A |
9/30/2018 | 1,172 | 185 | 57 | 226 | N/A |
6/30/2018 | 1,121 | 173 | N/A | 225 | N/A |
3/31/2018 | 1,093 | 162 | N/A | 196 | N/A |
12/31/2017 | 1,081 | 161 | N/A | 175 | N/A |
9/30/2017 | 1,073 | 151 | N/A | 165 | N/A |
6/30/2017 | 1,089 | 157 | N/A | 169 | N/A |
3/31/2017 | 1,075 | 157 | N/A | 146 | N/A |
12/31/2016 | 1,052 | 154 | N/A | 157 | N/A |
9/30/2016 | 1,009 | 145 | N/A | 146 | N/A |
6/30/2016 | 971 | 142 | N/A | 129 | N/A |
3/31/2016 | 926 | 136 | N/A | 155 | N/A |
12/31/2015 | 884 | 118 | N/A | 143 | N/A |
9/30/2015 | 850 | 111 | N/A | 150 | N/A |
6/30/2015 | 781 | 89 | N/A | 128 | N/A |
3/31/2015 | 734 | 76 | N/A | 113 | N/A |
12/31/2014 | 684 | 72 | N/A | 111 | N/A |
9/30/2014 | 646 | 71 | N/A | 93 | N/A |
6/30/2014 | 620 | 67 | N/A | 110 | N/A |
3/31/2014 | 604 | 68 | N/A | 97 | N/A |
12/31/2013 | 588 | 66 | N/A | 90 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SDMH.F's forecast earnings growth (31.9% per year) is above the savings rate (2.6%).
Earnings vs Market: SDMH.F's earnings (31.9% per year) are forecast to grow faster than the US market (15.4% per year).
High Growth Earnings: SDMH.F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SDMH.F's revenue (10.5% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: SDMH.F's revenue (10.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SDMH.F's Return on Equity is forecast to be low in 3 years time (13.7%).